Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 6e-05 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.005 |